UCB SA (UNC.DE) Fundamental Analysis & Valuation

FRA:UNC • BE0003739530

Current stock price

263.9 EUR
+7.6 (+2.97%)
Last:

This UNC.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. UNC.DE Profitability Analysis

1.1 Basic Checks

  • UNC had positive earnings in the past year.
  • In the past year UNC had a positive cash flow from operations.
  • UNC had positive earnings in each of the past 5 years.
  • UNC had a positive operating cash flow in each of the past 5 years.
UNC.DE Yearly Net Income VS EBIT VS OCF VS FCFUNC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • UNC's Return On Assets of 8.58% is fine compared to the rest of the industry. UNC outperforms 66.67% of its industry peers.
  • UNC has a better Return On Equity (14.34%) than 60.78% of its industry peers.
  • UNC has a Return On Invested Capital (10.29%) which is comparable to the rest of the industry.
  • UNC had an Average Return On Invested Capital over the past 3 years of 5.76%. This is significantly below the industry average of 13.61%.
  • The last Return On Invested Capital (10.29%) for UNC is above the 3 year average (5.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.58%
ROE 14.34%
ROIC 10.29%
ROA(3y)5.64%
ROA(5y)5.4%
ROE(3y)9.59%
ROE(5y)9.2%
ROIC(3y)5.76%
ROIC(5y)5.83%
UNC.DE Yearly ROA, ROE, ROICUNC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

1.3 Margins

  • UNC has a better Profit Margin (20.13%) than 76.47% of its industry peers.
  • UNC's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 25.98%, UNC is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Operating Margin of UNC has grown nicely.
  • With a decent Gross Margin value of 74.29%, UNC is doing good in the industry, outperforming 68.63% of the companies in the same industry.
  • UNC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.98%
PM (TTM) 20.13%
GM 74.29%
OM growth 3Y27.72%
OM growth 5Y4.58%
PM growth 3Y38.49%
PM growth 5Y8.01%
GM growth 3Y2.17%
GM growth 5Y-0.06%
UNC.DE Yearly Profit, Operating, Gross MarginsUNC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

7

2. UNC.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UNC is creating some value.
  • UNC has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for UNC has been increased compared to 5 years ago.
  • The debt/assets ratio for UNC has been reduced compared to a year ago.
UNC.DE Yearly Shares OutstandingUNC.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
UNC.DE Yearly Total Debt VS Total AssetsUNC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 5.81 indicates that UNC is not in any danger for bankruptcy at the moment.
  • UNC has a Altman-Z score of 5.81. This is amongst the best in the industry. UNC outperforms 82.35% of its industry peers.
  • UNC has a debt to FCF ratio of 1.22. This is a very positive value and a sign of high solvency as it would only need 1.22 years to pay back of all of its debts.
  • UNC has a Debt to FCF ratio of 1.22. This is amongst the best in the industry. UNC outperforms 86.27% of its industry peers.
  • UNC has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
  • UNC has a Debt to Equity ratio of 0.20. This is in the better half of the industry: UNC outperforms 74.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.22
Altman-Z 5.81
ROIC/WACC1.3
WACC7.92%
UNC.DE Yearly LT Debt VS Equity VS FCFUNC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that UNC should not have too much problems paying its short term obligations.
  • UNC's Current ratio of 1.38 is in line compared to the rest of the industry. UNC outperforms 49.02% of its industry peers.
  • UNC has a Quick Ratio of 1.04. This is a normal value and indicates that UNC is financially healthy and should not expect problems in meeting its short term obligations.
  • UNC has a Quick ratio of 1.04. This is comparable to the rest of the industry: UNC outperforms 52.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.04
UNC.DE Yearly Current Assets VS Current LiabilitesUNC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

7

3. UNC.DE Growth Analysis

3.1 Past

  • UNC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.60%, which is quite impressive.
  • Measured over the past years, UNC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.26% on average per year.
  • Looking at the last year, UNC shows a very strong growth in Revenue. The Revenue has grown by 25.83%.
  • UNC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.68% yearly.
EPS 1Y (TTM)100.6%
EPS 3Y31.73%
EPS 5Y13.26%
EPS Q2Q%123.53%
Revenue 1Y (TTM)25.83%
Revenue growth 3Y11.95%
Revenue growth 5Y7.68%
Sales Q2Q%26.57%

3.2 Future

  • Based on estimates for the next years, UNC will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.75% on average per year.
  • Based on estimates for the next years, UNC will show a quite strong growth in Revenue. The Revenue will grow by 10.92% on average per year.
EPS Next Y5.7%
EPS Next 2Y16.16%
EPS Next 3Y18.54%
EPS Next 5Y16.75%
Revenue Next Year11.39%
Revenue Next 2Y11.92%
Revenue Next 3Y11.93%
Revenue Next 5Y10.92%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UNC.DE Yearly Revenue VS EstimatesUNC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
UNC.DE Yearly EPS VS EstimatesUNC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

3

4. UNC.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 26.42, UNC can be considered very expensive at the moment.
  • UNC's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.89, UNC is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 24.99, the valuation of UNC can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as UNC.
  • UNC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 38.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.42
Fwd PE 24.99
UNC.DE Price Earnings VS Forward Price EarningsUNC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • UNC's Enterprise Value to EBITDA is on the same level as the industry average.
  • UNC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 27.87
EV/EBITDA 19.22
UNC.DE Per share dataUNC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • UNC has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as UNC's earnings are expected to grow with 18.54% in the coming years.
PEG (NY)4.64
PEG (5Y)1.99
EPS Next 2Y16.16%
EPS Next 3Y18.54%

3

5. UNC.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.39%, UNC is not a good candidate for dividend investing.
  • UNC's Dividend Yield is slightly below the industry average, which is at 1.89.
  • With a Dividend Yield of 0.39, UNC pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.39%

5.2 History

  • The dividend of UNC has a limited annual growth rate of 2.20%.
Dividend Growth(5Y)2.2%
Div Incr Years0
Div Non Decr Years0
UNC.DE Yearly Dividends per shareUNC.DE Yearly Dividends per shareYearly Dividends per share 2026 0.5 1

5.3 Sustainability

  • UNC pays out 16.94% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of UNC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP16.94%
EPS Next 2Y16.16%
EPS Next 3Y18.54%
UNC.DE Yearly Income VS Free CF VS DividendUNC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
UNC.DE Dividend Payout.UNC.DE Dividend Payout, showing the Payout Ratio.UNC.DE Dividend Payout.PayoutRetained Earnings

UNC.DE Fundamentals: All Metrics, Ratios and Statistics

UCB SA

FRA:UNC (4/17/2026, 7:00:00 PM)

263.9

+7.6 (+2.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)07-26
Inst Owners40.85%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap51.33B
Revenue(TTM)7.74B
Net Income(TTM)1.56B
Analysts74.81
Price Target259.57 (-1.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.39%
Yearly Dividend1.39
Dividend Growth(5Y)2.2%
DP16.94%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.29%
PT rev (3m)-1.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.66%
EPS NY rev (3m)2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE 26.42
Fwd PE 24.99
P/S 6.63
P/FCF 27.87
P/OCF 22.41
P/B 4.72
P/tB 22.04
EV/EBITDA 19.22
EPS(TTM)9.99
EY3.79%
EPS(NY)10.56
Fwd EY4%
FCF(TTM)9.47
FCFY3.59%
OCF(TTM)11.78
OCFY4.46%
SpS39.8
BVpS55.87
TBVpS11.97
PEG (NY)4.64
PEG (5Y)1.99
Graham Number112.062 (-57.54%)
Profitability
Industry RankSector Rank
ROA 8.58%
ROE 14.34%
ROCE 14.62%
ROIC 10.29%
ROICexc 12.64%
ROICexgc 53.22%
OM 25.98%
PM (TTM) 20.13%
GM 74.29%
FCFM 23.8%
ROA(3y)5.64%
ROA(5y)5.4%
ROE(3y)9.59%
ROE(5y)9.2%
ROIC(3y)5.76%
ROIC(5y)5.83%
ROICexc(3y)6.83%
ROICexc(5y)6.79%
ROICexgc(3y)30.47%
ROICexgc(5y)36.26%
ROCE(3y)8.18%
ROCE(5y)8.29%
ROICexgc growth 3Y18.32%
ROICexgc growth 5Y-5.98%
ROICexc growth 3Y44.94%
ROICexc growth 5Y7.84%
OM growth 3Y27.72%
OM growth 5Y4.58%
PM growth 3Y38.49%
PM growth 5Y8.01%
GM growth 3Y2.17%
GM growth 5Y-0.06%
F-Score9
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.22
Debt/EBITDA 0.83
Cap/Depr 71.61%
Cap/Sales 5.8%
Interest Coverage 15.71
Cash Conversion 86.85%
Profit Quality 118.23%
Current Ratio 1.38
Quick Ratio 1.04
Altman-Z 5.81
F-Score9
WACC7.92%
ROIC/WACC1.3
Cap/Depr(3y)55.86%
Cap/Depr(5y)76.64%
Cap/Sales(3y)5.68%
Cap/Sales(5y)6.46%
Profit Quality(3y)111.45%
Profit Quality(5y)122.7%
High Growth Momentum
Growth
EPS 1Y (TTM)100.6%
EPS 3Y31.73%
EPS 5Y13.26%
EPS Q2Q%123.53%
EPS Next Y5.7%
EPS Next 2Y16.16%
EPS Next 3Y18.54%
EPS Next 5Y16.75%
Revenue 1Y (TTM)25.83%
Revenue growth 3Y11.95%
Revenue growth 5Y7.68%
Sales Q2Q%26.57%
Revenue Next Year11.39%
Revenue Next 2Y11.92%
Revenue Next 3Y11.93%
Revenue Next 5Y10.92%
EBIT growth 1Y40.24%
EBIT growth 3Y42.99%
EBIT growth 5Y12.61%
EBIT Next Year63.68%
EBIT Next 3Y33.12%
EBIT Next 5Y25.36%
FCF growth 1Y100.22%
FCF growth 3Y35.04%
FCF growth 5Y20.27%
OCF growth 1Y84.46%
OCF growth 3Y26.98%
OCF growth 5Y16.21%

UCB SA / UNC.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UCB SA?

ChartMill assigns a fundamental rating of 6 / 10 to UNC.DE.


What is the valuation status for UNC stock?

ChartMill assigns a valuation rating of 3 / 10 to UCB SA (UNC.DE). This can be considered as Overvalued.


What is the profitability of UNC stock?

UCB SA (UNC.DE) has a profitability rating of 7 / 10.


What is the expected EPS growth for UCB SA (UNC.DE) stock?

The Earnings per Share (EPS) of UCB SA (UNC.DE) is expected to grow by 5.7% in the next year.


How sustainable is the dividend of UCB SA (UNC.DE) stock?

The dividend rating of UCB SA (UNC.DE) is 3 / 10 and the dividend payout ratio is 16.94%.